The humeral reconstruction prosthesis is designed to address proximal humeral bone loss and reconstruction after tumour resections. Credit: Exactech.

Exactech has launched its new modular device, Equinoxe Humeral Reconstruction Prosthesis, for clinical use in Europe.

The humeral reconstruction prosthesis is developed for patient-specific sizing and intraoperative flexibility.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The shoulder implant provides a stable solution for complex and challenging cases with significant humeral bone loss.

Equinoxe is claimed to be the first modular device in the US that is also designed for reconstruction following tumour resections.

It also addresses straightforward cases and offers a number of options for achieving joint stability, regardless of proximal humeral resection length.

Initially introduced in the US in 2015, the device is used in anatomic oncology procedures and primary or revision arthroplasty procedures.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The company stated that the humeral reconstruction prosthesis has been used to treat more than 1,500 patients and is now available in Germany, Italy, Spain, France and the UK.

Exactech Extremities senior vice-president Chris Roche said: “The Humeral Reconstruction Prosthesis was the first reverse total shoulder arthroplasty (TSA) device cleared for use in the US for significant resection of the proximal humerus.

“It incorporates many unique design features intended to mitigate complications associated with these challenging cases, including collars available in 17 different sizes to achieve rotational stability and fixation for the full range of bone sizes.”

Equinoxe comes with a platform stem, several soft tissue attachments and multiple modular segments that enable reconstruction between 50mm-212.5mm and 60mm-222.5mm.

It also offers biomechanical advantages, such as rotational stability, due to its unique plasma/hydroxyapatite (HA) coated collars, which provide fixation and optimal fit.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact